Skip to Main Content (Press Enter)

×
Home
Corsi
Insegnamenti
Professioni
Pubblicazioni
Progetti
Persone
Terza Missione
Competenze
Settori
Strutture

UNI-FIND

|

UNI-FIND

unito.it

×
Home
Corsi
Insegnamenti
Professioni
Pubblicazioni
Progetti
Persone
Terza Missione
Competenze
Settori
Strutture

Pubblicazioni

HAEMATOLOGICA

Rivista

Codice:

E215747

ISSN:

1592-8721

Dati Generali

Dati Generali

Pubblicazioni (34)

Ordina Pubblicazioni:

ascendente
decrescente

2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde

Articolo

A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia

Articolo

A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents

Articolo

Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins

Articolo

Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma

Articolo

Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients.

Articolo

Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis

Articolo

Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus Acute Lymphoblastic Leukemia study

Articolo

Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)

Articolo

Duality of Nrf2 in iron-overload cardiomyopathy

Articolo

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma

Articolo

Factor VIII promotes angiogenesis and vessel stability regulating extracellular matrix proteins

Articolo

Heme and erythropoieis: more than a structural role

Articolo

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib.

Articolo

High rate of durable responses with undetectable minimal residual disease with frontline venetoclax and rituximab in young and fit patients with chronic lymphocytic leukemia and an adverse biologic profile: results of the gimema phase II LLC1518 - 'Veritas' study

Articolo

IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA

Abstract

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma

Articolo

Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia

Abstract

Increased regulatory T-cell numbers in Chronic Lymphocytic Leukemia patients with progressive disease

Abstract

Lenalidomide in the treatment of plasma cell dyscrasia: state of the art and perspectives.

Articolo

Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.

Articolo

Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Articolo

Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis

Articolo

Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study

Articolo

NEW PROSPECTS FOR INDUCTION OF ANTI-LYMPHOMA IMMUNITY USING DNA VACCINES EXPRESSING CHEMOKINE-PARTICLES

Contributo in Atti di convegno

Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy

Articolo

Psychological distress and oral chemotherapy: a pilot study.

Abstract

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

Articolo

Role of PD-1/PD-L1 axis in the immune paresis of bone marrow Vγ9Vδ2 T cells in multiple myeloma

Abstract

The association of dexamethasone + simvastatin to overcome environment-mediated chemoresistance of chronic lymphocytic leukemia (CLL) cells

Abstract

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespective of the disease status.

Articolo

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy

Articolo

Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel

Articolo

Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and research

Articolo

No Results Found

«
‹

{pageNumber}

›
»

{startItem} - {endItem} di {itemsNumber}

Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 24.10.2.1